Immutep Limited

NASDAQ:IMMP

Biotechnology

Healthcare
$0.37 +0.64%

+$0.00 today

Market cap
$55.01M
Beta
2.24
P/E (TTM)
-0.9
EPS (TTM)
-$0.06
52W Low $0.29High $3.53

Volume 3.10M

Average 13.46M

Income Statement

Follow revenue through to earnings.

Revenue

$5.04M

FY 2025 · Annual

+31.3% YoY

Operating Income

-$126.42M

FY 2025 · Annual

Net Income

-$61.43M

FY 2025 · Annual

Income Statement

AUD
Metric
FY2021
Jun 2021
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
Revenue3.86M170.37K3.51M3.84M5.04M
Cost of Revenue17.24M2.06M2.06M41.55M61.41M
Gross Profit(13.37M)(1.89M)1.44M(37.7M)(56.37M)
Gross Margin-346.2%-1111.2%41.2%-981.4%-1117.6%
Research & Development17.24M31.34M28.79M41.55M61.41M
Selling, General & Admin6.28M7.21M14.08M8.85M8.64M
Operating Expenses18.3M32.55M44.94M50.4M70.06M
Depreciation & Amortization1.89M1.84M1.86M2.01M2.13M
EBITDA(17.77M)(31.87M)(39.57M)(44.54M)(62.88M)
EBITDA Margin-460.0%-18708.9%-1128.8%-1159.4%-1246.6%
Operating Income(31.68M)(33.94M)(77.69M)(88.1M)(126.42M)
Operating Margin-820.0%-19920.0%-2216.0%-2293.3%-2506.5%
Interest Income105.33K224.52K939K3.88M5.25M
Interest Expense9.83K92.43K20.4K30.59K24.01K
Other Income / Expenses1.77M1.63M37.79M45.39M64.99M
Income Before Tax(29.9M)(32.21M)(39.9M)(42.72M)(61.43M)
Pre-Tax Margin-774.1%-18906.5%-1138.0%-1111.9%-1218.0%
Income Tax Expense3334000
Net Income(29.9M)(32.21M)(39.9M)(42.72M)(61.43M)
Net Margin-774.1%-18906.5%-1138.0%-1111.9%-1218.0%
EPS (Basic)(0.49)(0.37)(0.44)(0.36)(0.42)
EPS (Diluted)(0.49)(0.37)(0.44)(0.36)(0.42)
Weighted Avg Shares60.43M86.23M90.06M119.99M145.58M
Weighted Avg Shares (Diluted)60.43M86.23M90.06M120.11M145.58M

IMMP Earnings Waterfall · TTM

NASDAQ:IMMP · Revenue to Net Income

Key Ratios

EPS$-0.90
Gross Margin-1075.2%
Net Margin-1189.1%
P/E Ratio-3.9
P/S Ratio167.4

Analysis

$12.8M of revenue converted into -$127.8M of net income for the selected period. Gross margin is -1075.2% and net margin is -1189.1%, showing how much revenue survives after costs and taxes. EPS is $-0.90, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingSep 11, 2026
6-K6-K filingSep 2, 2026
6-K6-K filingAug 3, 2026
6-K6-K filingJul 14, 2026
6-K6-K filingJun 5, 2026

How much revenue does IMMP generate?

Immutep Limited (IMMP) reported $5.04M of revenue in fiscal 2025.

Is IMMP profitable?

Immutep Limited (IMMP) reported -$61.43M of net income, with a net margin of -1218.0%.